Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Ayesha C Qureshi"'
Autor:
Azfar Zaman, Bernard Prendergast, David Hildick-Smith, Daniel Blackman, Richard Anderson, Mark S Spence, Darren Mylotte, David Smith, Ben Wilding, Chris Chapman, Kirsty Atkins, Kevin G Pollock, Ayesha C Qureshi, Adrian Banning
Publikováno v:
Interventional Cardiology: Reviews, Research, Resources, Vol 18, Iss , Pp - (2023)
Transcatheter aortic valve implantation (TAVI) is an effective and established treatment for symptomatic aortic stenosis. However, there is a lack of consensus concerning the need for peri- and post-procedural anti-thrombotic medication. Contemporary
Externí odkaz:
https://doaj.org/article/80578807c09b46e3aaec3ad589cdbfbf
Autor:
Kuan Ken Lee, Dimitrios Doudesis, Rong Bing, Federica Astengo, Jesus R. Perez, Atul Anand, Shauna McIntyre, Nicholas Bloor, Belinda Sandler, Steven Lister, Kevin G. Pollock, Ayesha C. Qureshi, David A. McAllister, Anoop S. V. Shah, Nicholas L. Mills
Publikováno v:
Lee, K K, Doudesis, D, Bing, R, Astengo, F, R. Perez, J, Anand, A, McIntyre, S, Bloor, N, Sandler, B, Lister, S, Pollock, K G J, Qureshi, A C, McAllister, D A, Shah, A SV & Mills, N L 2023, ' Sex-differences in oral anticoagulation therapy in patients hospitalized with atrial fibrillation : a nationwide cohort study ', Journal of the American Heart Association . https://doi.org/10.1161/JAHA.122.027211
Background Important disparities in the treatment and outcomes of women and men with atrial fibrillation (AF) are well recognized. Whether introduction of direct oral anticoagulants has reduced disparities in treatment is uncertain. Methods and Resul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79d2648a500880441b22e368ac6bd180
https://www.pure.ed.ac.uk/ws/files/331035865/JAHA.122.027211.pdf
https://www.pure.ed.ac.uk/ws/files/331035865/JAHA.122.027211.pdf
Autor:
Bernard J. Gersh, Aung Myat, Bryan Williams, Deepak L. Bhatt, John G.F. Cleland, Simon Redwood, Simon Thackray, Ayesha C. Qureshi
Publikováno v:
Circulation: Cardiovascular Interventions. 6:184-197
Resistant hypertension (RHTN) is defined as the failure to achieve goal blood pressure (BP), despite adherence to maximally tolerated doses of an appropriate regimen of 3 antihypertensive agents, including a diuretic.1,2 Interest surrounding its eval
Autor:
Ayesha C. Qureshi, Hans-Peter Stoll, Renate Koppensteiner, Mariella Van Ransbeeck, Dimitris Siablis, Iris Baumgartner, Achilles Investigators, Dierk Scheinert, Thomas Zeller, Hans Krankenberg, Philip Commeau, Marc Bosiers, Konstantinos Katsanos, Johannes Lammer
Publikováno v:
Journal of the American College of Cardiology. 60(22):2290-2295
Objectives The study investigated the efficacy and safety of a balloon expandable, sirolimus-eluting stent (SES) in patients with symptomatic infrapopliteal arterial disease. Background Results of infrapopliteal interventions using balloon angioplast
Diabetes mellitus and cardiovascular disease are two closely related diseases. In patients with both stable and unstable coronary artery disease (CAD), there is a high prevalence of diabetes and increased rates of both undiagnosed diabetes and impair
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16d96ec0c0b176d58ab163bd2c544934
https://ora.ox.ac.uk/objects/uuid:44828c9d-9da2-4e09-b6b9-8144b43deeb9
https://ora.ox.ac.uk/objects/uuid:44828c9d-9da2-4e09-b6b9-8144b43deeb9
Autor:
Sean Gallagher, Kevin J. Beatt, Malcolm Finlay, Akhil Kapur, Petros Nihoyannopoulos, Ayesha C. Qureshi, Michael Roughton, Roger J. Hall, Iqbal S. Malik, Jamil Mayet
Publikováno v:
European Journal of Echocardiography. 12:904-909
Aims The CARDia (Coronary Artery Revascularization in Diabetes) trial compared coronary artery bypass grafting (CABG) and optimal percutaneous coronary intervention (PCI) in diabetic patients with multivessel coronary disease. Patients enrolled had s
Autor:
Iqbal S. Malik, Andreas Baumbach, Akhil Kapur, Gianni D Angelini, Kevin J. Beatt, Marcus Flather, Jeremy N Butts, Kenneth P. Morgan, Roger Hall, Petros Nihoyannopoulos, Keith G. Oldroyd, Michael Roughton, Jens Peder Bagger, Ayesha C. Qureshi, Adam de Belder, Mark A. de Belder
Publikováno v:
Journal of the American College of Cardiology. 55:432-440
Objectives The purpose of this study was to compare the safety and efficacy of percutaneous coronary intervention (PCI) with stenting against coronary artery bypass grafting (CABG) in patients with diabetes and symptomatic multivessel coronary artery
Autor:
Nevo ResElution-I Investigators, Ayesha C Qureshi, John A. Ormiston, Christian Spaulding, Stefan Verheye, Alexandre Abizaid, Leif Thuesen, Jean Fajadet, Joseph Dens, Nathalie Macours, Laura Mauri, Joachim Schofer
Publikováno v:
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 9(6)
Aims To assess the two-year clinical follow-up of the NEVO RES-1 study, a randomised comparison between the NEVO™ sirolimus-eluting coronary stent system (NEVO SES) and the TAXUS Liberte™ paclitaxel-eluting stent (TAXUS PES). Methods and results
Autor:
Dierk, Scheinert, Konstantinos, Katsanos, Thomas, Zeller, Renate, Koppensteiner, Philip, Commeau, Marc, Bosiers, Hans, Krankenberg, Iris, Baumgartner, Dimitris, Siablis, Johannes, Lammer, Mariella, Van Ransbeeck, Ayesha C, Qureshi, Hans-Peter, Stoll, Pierre-Edouard, Magnan
Publikováno v:
Journal of the American College of Cardiology. 60(22)
The study investigated the efficacy and safety of a balloon expandable, sirolimus-eluting stent (SES) in patients with symptomatic infrapopliteal arterial disease.Results of infrapopliteal interventions using balloon angioplasty and/or bare stents ar
Autor:
Marcus Flather, Julian W Strange, Davide Bartolini, Ayesha C. Qureshi, Malcolm Finlay, Roger Hall, Akhil Kapur
Publikováno v:
Journal of cardiovascular medicine (Hagerstown, Md.). 11(1)
The aim of the Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes study was to assess percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) as treatments for multivessel coronary artery disease in diabeti